Larger lessons from the women's health initiative

Epidemiology

Volumn 14, Issue 1, 2003, Pages 6-7

  Piantadosi, Steven ^a,b,c,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Department of Oncology ^*  (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; PROGESTERONE DERIVATIVE;

BREAST CANCER; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; EPIDEMIOLOGICAL DATA; FOLLOW UP; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; NOTE; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; STROKE; UNITED STATES; ARTICLE; COHORT ANALYSIS; EPIDEMIOLOGY; ESTROGEN THERAPY; FEMALE; REPRODUCIBILITY; WOMEN'S HEALTH;

COHORT STUDIES; EPIDEMIOLOGIC RESEARCH DESIGN; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; PROGESTERONE CONGENERS; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; WOMEN'S HEALTH;

EID: 0037208922     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-200301000-00004     Document Type: Note

References (5)

1. WHI Investigators Writing Group, Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-333.
2. Stampfer M, Colditz G. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
3. Grady D, Rubin SM, Petitti DB. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-1037.
4. Benson K, Hartz AJ. A comparison of observational studies and randomized controlled trials. N Engl J Med 2000;342:1878-1886.
5. Concato J, Shah N, Horwitz RI. Randomized controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-1892.